Gemcitabine plus nab-paclitaxel until progression or...

Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)

Rinaldi, Yves, Pointet, Anne-Laure, Khemissa Akouz, Faiza, Le Malicot, Karine, Wahiba, Bidaut, Louafi, Samy, Gratet, Alain, Miglianico, Laurent, Laharie, Hortense, Bouhier Leporrier, Karine, Thirot Bi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
136
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2020.05.018
Date:
September, 2020
File:
PDF, 571 KB
2020
Conversion to is in progress
Conversion to is failed